Five Studies Are the Entire Field of TMS-Plus-Reconsolidation
- A PRISMA-2020 systematic review, preregistered in PROSPERO, searched PubMed/MEDLINE, Scopus, and Web of Science without date restriction for human studies combining transcranial magnetic stimulation (TMS) with a recognizable memory-reactivation procedure.
- Five studies met inclusion criteria: three on fear memory, one on episodic memory, one on procedural memory, using either 1 Hz repetitive TMS or continuous theta-burst stimulation, mostly targeting the dorsolateral prefrontal cortex.
- In the fear studies, postreactivation prefrontal stimulation was generally associated with attenuated physiological fear expression, and in the strongest designs, reduced return of fear; in the episodic study, stimulation was linked to enhanced delayed recall; in the procedural study, it blocked subsequent offline memory modification.
- Four of the five studies gave comparatively strong reconsolidation-oriented support through explicit reactivation, critical controls, and delayed testing; one translational clinical-analog study returned a null primary effect, and risk of bias across the set ranged from low to high, driven mainly by randomization reporting and prespecified analyses.
A systematic review is only as informative as what it finds, and this one, run to PRISMA standard with a registered protocol, found a field five studies deep. That number is itself the finding: readers who assume TMS-based reconsolidation editing is an established technique are working from a much smaller evidence base than they think.
What Five Studies Actually Cover
The studies split across three memory systems rather than clustering on one, using two stimulation approaches on largely one target region, the dorsolateral prefrontal cortex. Effects clustered in a plausible direction, less fear expression, better delayed recall, blocked offline modification, but plausible direction across five heterogeneous studies is a different claim from replicated effect.
The One Study That Did Not Work, and Why It Counts
One study, described by the reviewers as having the strongest translational design, a clinical-analog test closer to how the technique might eventually be used, produced a null primary result. The review treats that null finding as informative rather than discarding it, which is part of what separates this synthesis from a narrative summary built to make a technique look ready.
Current human evidence suggests that TMS can modulate postreactivation memory outcomes in ways that are, in some cases, compatible with a reconsolidation framework.
Five studies cannot support a pooled effect-size estimate, and the review itself notes methodological heterogeneity across stimulation type, memory system, and outcome measure as a barrier to any single summary conclusion.